Brigham and Women’s researchers discuss one-two punch that catches cancer cells in vulnerable state

By hitting breast cancer cells with a targeted therapeutic immediately after chemotherapy, researchers from Brigham and Women’s Hospital were able to target cancer cells during a transitional stage when they were most vulnerable, killing cells and shrinking tumors in the lab and in pre-clinical models. …read more

Source:: Cancer